Find clinical trials for Breast Cancer in Phoenix, AZ
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Breast Cancer trials near Phoenix, AZ, USA:
The purpose of this study is to test the safety and tolerability of PMD-026 in patients with metastatic breast cancer. PMD-026 is a ...
Phase 1, Phase 2
Gilbert, Arizona, United States and 9 other locations
Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies avail...
Phase 3
Phoenix, Arizona, United States and 78 other locations
growth factor receptor 2 negative (ER+/HER2-) advanced/metastatic breast cancer. The phase 1b part of the trial will determine the ...
Phase 1, Phase 2
Phoenix, Arizona, United States and 85 other locations
with pathology-confirmed HR-positive/HER2-negative metastatic breast cancer (MBC) following progression on or after at least two pr...
Phase 2
Phoenix, Arizona, United States and 52 other locations
This open-label research study is studying (Z)-endoxifen as a possible treatment for pre-menopausal women with ER+/HER2- breast cancer...
Phase 2
Phoenix, Arizona, United States and 13 other locations
mg in postmenopausal women with oestrogen receptor positive advanced breast cancer who have failed on a previous endocrine treatmen...
Phase 3
Casa Grande, Arizona, United States and 105 other locations
of phosphoinositide-3-kinase (PI3K)-gamma, in combinations with Tecentriq and Abraxane (nab-paclitaxel) in front-line triple negative breast...
Phase 2
Chandler, Arizona, United States and 23 other locations
in participants with intermediate-risk HR+/HER2- early-stage breast cancer. Based on ctDNA test results, participants will either s...
Phoenix, Arizona, United States and 48 other locations
growth factor receptor (HER)2-low, hormone receptor (HR) positive breast cancer patients whose disease has progressed on endocrine ...
Phase 3
Scottsdale, Arizona, United States and 292 other locations
study drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or metastatic breast...
Phase 1
Phoenix, Arizona, United States and 73 other locations
Clinical trials
Research sites
Resources
Legal